El-Rayes B - Search Results

1

Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.

Allaw MB, Switchenko JM, Khalil L, Wu C, Alese OB, Akce M, Draper A, Jones AT, El-Rayes B, Shaib W. Allaw MB, et al. Oncology. 2022;100(3):131-139. doi: 10.1159/000519605. Epub 2022 Jan 25. Oncology. 2022. PMID: 35078191 Free PMC article.

2

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers.

El-Rayes BF, Zalupski M, Bekai-Saab T, Heilbrun LK, Hammad N, Patel B, Urba S, Shields AF, Vaishampayan U, Dawson S, Almhanna K, Smith D, Philip PA. El-Rayes BF, et al. Ann Oncol. 2010 Oct;21(10):1999-2004. doi: 10.1093/annonc/mdq065. Epub 2010 Mar 23. Ann Oncol. 2010. PMID: 20332133 Free PMC article. Clinical Trial.

3

Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience.

Hammad N, Heilbrun LK, Gupta S, Tageja N, Philip PA, Shields AF, Smith D, El-Rayes BF. Hammad N, et al. Am J Clin Oncol. 2011 Apr;34(2):135-9. doi: 10.1097/COC.0b013e3181dbb710. Am J Clin Oncol. 2011. PMID: 20523206 Free PMC article.

4

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy.

Hammad N, Heilbrun LK, Philip PA, Shields AF, Zalupski MM, Venkatramanamoorthy R, El-Rayes BF. Hammad N, et al. Asia Pac J Clin Oncol. 2010 Jun;6(2):98-105. doi: 10.1111/j.1743-7563.2010.01290.x. Asia Pac J Clin Oncol. 2010. PMID: 20565421 Free PMC article. Clinical Trial.

5

Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer.

Mobayed M, Heilbrun LK, Shields AF, Washington T, Venkatramanamoorthy R, Philip PA, El-Rayes BF. Mobayed M, et al. Case Rep Oncol. 2009 Nov 21;2(3):220-228. doi: 10.1159/000250082. Case Rep Oncol. 2009. PMID: 20737041 Free PMC article.

6

Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection.

Maithel SK, Coban I, Kneuertz PJ, Kooby DA, El-Rayes BF, Kauh JS, Sarmiento J, Staley CA 3rd, Volkan Adsay N. Maithel SK, et al. Ann Surg Oncol. 2011 Sep;18(9):2699-705. doi: 10.1245/s10434-011-1610-x. Epub 2011 Mar 1. Ann Surg Oncol. 2011. PMID: 21360249

7

Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.

Patel SH, Kneuertz PJ, Delgado M, Kooby DA, Staley CA 3rd, El-Rayes BF, Kauh JS, Sarmiento JM, Hanish S, Cohen C, Farris AB 3rd, Maithel SK. Patel SH, et al. Ann Surg Oncol. 2011 Nov;18(12):3384-90. doi: 10.1245/s10434-011-1775-3. Epub 2011 May 18. Ann Surg Oncol. 2011. PMID: 21590454

8

Chemotherapeutic strategies in advanced or metastatic pancreatic adenocarcinoma.

Zafar SF, El-Rayes BF. Zafar SF, et al. Am J Clin Oncol. 2014 Apr;37(2):194-200. doi: 10.1097/COC.0b013e318248d8bb. Am J Clin Oncol. 2014. PMID: 22643564 Review.

9

Markers of resistance to anti-EGFR therapy in colorectal cancer.

Shaib W, Mahajan R, El-Rayes B. Shaib W, et al. J Gastrointest Oncol. 2013 Sep;4(3):308-18. doi: 10.3978/j.issn.2078-6891.2013.029. J Gastrointest Oncol. 2013. PMID: 23997942 Free PMC article.

10

HER2 in resected gastric cancer: Is there prognostic value?

Fisher SB, Fisher KE, Squires MH 3rd, Patel SH, Kooby DA, El-Rayes BF, Cardona K, Russell MC, Staley CA 3rd, Farris AB 3rd, Maithel SK. Fisher SB, et al. J Surg Oncol. 2014 Feb;109(2):61-6. doi: 10.1002/jso.23456. Epub 2013 Oct 10. J Surg Oncol. 2014. PMID: 24122802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page